VERILY LIFE SCIENCES LLC: $14.1M Department of Health and Human Services Federal Award
Summary
Verily Life Sciences LLC, a private entity, received a $14.1M NIH contract to build the SysBio FAIRPlex platform, a FAIR data ecosystem for systems biology. This contract supports biomedical data integration and analysis, benefiting the healthcare and technology sectors broadly but without direct public company exposure.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Verily Life Sciences, a private Alphabet subsidiary, won a $14.1M NIH contract for a systems biology data platform.
- 2.No publicly traded companies are directly impacted; the contract is a routine award in biomedical data infrastructure.
- 3.The contract reinforces federal support for FAIR data principles in healthcare research, benefiting the sector broadly.
Market Implications
This contract has no direct market implications for publicly traded stocks. The healthcare and technology sectors may see indirect tailwinds from continued NIH investment in data platforms, but no specific company is positioned to benefit from this award alone. Investors should monitor broader trends in biomedical data integration rather than this single contract.
Full Analysis
The contract awarded to Verily Life Sciences LLC by the National Institutes of Health (NIH) is for the development of SysBio FAIRPlex, a platform designed to enable FAIR (Findable, Accessible, Interoperable, Reusable) principles for systems biology data. The $14.1M award spans three years (2024-2027) and aims to accelerate biomedical research by harmonizing data from multiple sources and providing tools for exploration and analysis. Verily is a private company under Alphabet Inc., but it is not a publicly traded subsidiary, so no direct ticker mapping is possible.
As a private entity, this contract does not directly impact publicly traded companies' financials. However, the contract signals continued federal investment in biomedical data infrastructure, which benefits the broader healthcare and technology sectors. Companies involved in cloud computing, data analytics, and life sciences tools may indirectly benefit from increased demand for similar platforms, but no specific public company is named as a recipient or subcontractor.
No related legislation from the provided bill signals directly authorizes or appropriates funds for this specific contract. The contract is funded through NIH's existing appropriations for systems biology research. While bills like S4130 (COST Act) and S5237 (antibiotic resistance research) touch on technology and healthcare, they do not have a direct causal link to this award.
Supply chain beneficiaries are not identifiable from the contract data, as Verily is the sole recipient and no subcontractors are listed. The contract's focus on data platform development suggests potential involvement of cloud service providers or data integration firms, but these are speculative and not confirmed.
Historically, NIH contracts for data infrastructure are routine and moderate in size, typically not moving stock prices of large public companies. The impact is limited to the private recipient and the broader sector trend toward digital health and data-driven research.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MAGNENDO CORP: $17.3M Department of Health and Human Services Federal Award
HENSEL PHELPS CONSTRUCTION CO: $145M Department of Health and Human Services Contract
SIEMENS HEALTHINEERS ENDOVASCULAR ROBOTICS, INC.: $14.5M Department of Health and Human Services Federal Award
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Presidential Determination Pursuant to Section 101 of the Defense Production Act of 1950, as Amended, on Recoverable Critical Minerals and Materials
This memorandum invokes the Defense Production Act (DPA) Section 101 to declare that recoverable critical minerals and materials (such as black mass, end-of-life rare-earth magnets, and scrap) are essential to national defense and that the U.S. cannot meet defense needs without disrupting civilian markets. It directs the Secretary of Commerce to issue regulations and take actions—including priority contracts and supply-chain interventions—to rapidly expand domestic recovery and processing of these materials, while explicitly excluding copper scrap already covered by a separate proclamation.
Securing America’s Defense Supply Chains and Ensuring Domestic Acquisition of Critical Materials
This executive order restricts waivers for foreign-sourced critical materials in defense contracts, effective January 1, 2027, and mandates that defense contractors map their supply chains from raw materials to end products, vet subcontractors for risks, and prohibit covered materials from unreliable foreign suppliers. It directs the Secretary of War to enforce strict compliance, including requiring mitigation plans for any non-compliant materials and establishing penalties for fraud or willful noncompliance.
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Contract Details
Recipient
VERILY LIFE SCIENCES LLC
Award Amount
$14,073,347
Awarding Agency
Department of Health and Human Services
Sub-Agency
National Institutes of Health
Contract Type
DIRECT PAYMENT FOR SPECIFIED USE, AS A SUBSIDY OR OTHER NON-REIMBURSABLE DIRECT FINANCIAL AID (C)
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →